$CHHE
China Health Industries Holdings, Inc. Stock $chhe

$chhe Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-K Financial Statement

#000114420413055291 Filed on October 15, 2013

Income Statement

Concept	2013 Q1	2013	2012 Q4
Revenue	$2.725M	$8.996M	$2.431M
YoY Change	-75.78%	-84.74%	-89.86%
Cost Of Revenue	$2.515M	$7.732M	$1.915M
YoY Change	-60.75%	-77.86%	-86.7%
Gross Profit	$210.6K	$1.263M	$516.1K
YoY Change	-95.65%	-94.74%	-94.61%
Gross Profit Margin	7.73%	14.04%	21.23%
Selling, General & Admin	$354.0K	$1.888M	$641.2K
YoY Change	-37.55%	-59.41%	-71.96%
% of Gross Profit	168.11%	149.4%	124.24%
Research & Development	$120.5K	$444.9K	$120.1K
YoY Change	0.28%	42.99%	0.05%
% of Gross Profit	57.22%	35.22%	23.27%
Depreciation & Amortization	$48.91K	$412.0K	$161.8K
YoY Change	63.05%	273.67%	709.09%
% of Gross Profit	23.23%	32.61%	31.36%
Operating Expenses	$523.4K	$2.612M	$923.1K
YoY Change	-29.12%	-48.03%	-61.89%
Operating Profit	-$312.8K	-$1.348M	-$407.0K
YoY Change	-107.62%	-107.1%	-105.69%
Interest Expense	$22.16K	$121.7K	$32.52K
YoY Change	220.89%		393.06%
% of Operating Profit
Other Income/Expense, Net	$44.74K	$125.7K	$29.44K
YoY Change	-41.1%	-58.75%	-58.05%
Pretax Income	-$268.1K	-$1.223M	-$377.6K
YoY Change	-106.41%	-106.34%	-105.23%
Income Tax	$93.00	$23.93K	$15.98K
% Of Pretax Income
Net Earnings	-$268.1K	-$1.247M	-$393.5K
YoY Change	-107.38%	-108.61%	-107.6%
Net Earnings / Revenue	-9.84%	-13.86%	-16.19%
Basic Earnings Per Share		-$0.02
Diluted Earnings Per Share	-$4.338K	-$0.02	-$6.266K
COMMON SHARES
Basic Shares Outstanding		62.24M shares
Diluted Shares Outstanding		62.24M shares

Balance Sheet

Concept	2013 Q1	2013	2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.94M	$28.84M	$49.87M
YoY Change	21.73%	-35.19%	80.62%
Cash & Equivalents	$29.86M	$28.84M	$33.83M
Short-Term Investments
Other Short-Term Assets	$550.0K	$230.0K	$460.0K
YoY Change	-20.29%	-67.61%	-41.03%
Inventory	$196.6K	$160.0K	$217.1K
Prepaid Expenses	$545.1K		$461.4K
Receivables	$4.631K	$0.00	$1.074M
Other Receivables	$24.44K	$16.31M	$24.05K
Total Short-Term Assets	$46.71M	$45.55M	$51.64M
YoY Change	-3.43%	-4.49%	3.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.561M	$3.260M	$1.135M
YoY Change	53.36%	100.0%	-32.81%
Goodwill
YoY Change
Intangibles	$5.687M		$859.3K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Total Long-Term Assets	-$5.135M	$8.890M	-$9.964M
YoY Change	-187.48%	53.54%	-268.87%
TOTAL ASSETS
Total Short-Term Assets	$46.71M	$45.55M	$51.64M
Total Long-Term Assets	-$5.135M	$8.890M	-$9.964M
Total Assets	$41.58M	$54.44M	$41.68M
YoY Change	-23.34%	1.8%	-25.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$300.0K	$120.0K	$300.0K
YoY Change	1400.0%	-60.0%	-86.73%
Accrued Expenses	$240.0K	$220.0K	$220.0K
YoY Change	-54.72%	37.5%	-81.36%
Deferred Revenue
YoY Change
Short-Term Debt	$430.0K	$430.0K	$430.0K
YoY Change	0.0%	-2.27%	0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.260M	$990.0K	$1.270M
YoY Change	-33.71%	-25.0%	-82.58%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.260M	$990.0K	$1.270M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.260M	$990.0K	$1.270M
YoY Change	-33.68%	-25.0%	-82.58%
SHAREHOLDERS EQUITY
Retained Earnings	$47.54M		$47.81M
YoY Change
Common Stock	$1.468M		$1.468M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$52.91M	$53.45M	$53.02M
YoY Change
Total Liabilities & Shareholders Equity	$54.17M	$54.44M	$54.29M
YoY Change	-0.14%	1.8%	-3.06%

Cashflow Statement

Concept	2013 Q1	2013	2012 Q4
OPERATING ACTIVITIES
Net Income	-$268.1K	-$1.247M	-$393.5K
YoY Change	-107.38%	-108.61%	-107.6%
Depreciation, Depletion And Amortization	$48.91K	$412.0K	$161.8K
YoY Change	63.05%	273.67%	709.09%
Cash From Operating Activities	$1.060M	$5.177M	$3.450M
YoY Change	-89.55%	-75.22%	167.44%
INVESTING ACTIVITIES
Capital Expenditures	$766.00	$55.12K	$42.26K
YoY Change		-27.74%	-135.21%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	-$4.790M	-$6.495M	-$210.0K
YoY Change		1078.63%	75.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	50.00K	$421.8K	160.0K
YoY Change		27005.33%	-142.11%
NET CHANGE
Cash From Operating Activities	1.060M	$5.177M	3.450M
Cash From Investing Activities	-4.790M	-$6.495M	-210.0K
Cash From Financing Activities	50.00K	$421.8K	160.0K
Net Change In Cash	-3.680M	-$896.7K	3.400M
YoY Change	-136.29%	-104.41%	330.38%
FREE CASH FLOW
Cash From Operating Activities	$1.060M	$5.177M	$3.450M
Capital Expenditures	$766.00	$55.12K	$42.26K
Free Cash Flow	$1.059M	$5.122M	$3.408M
YoY Change	-89.55%	-75.4%	141.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011	us-gaap	Depreciation Depreciation	64448	USD
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2013	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2012Q4	dei	Entity Public Float EntityPublicFloat	8523126	USD
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	62239737	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	62239737	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	62239737	shares
CY2011Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62239737	shares
CY2012Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62239737	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62239737	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62239737	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62239737	shares
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28839609	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44504531	USD
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23744820	USD
CY2013Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4686	USD
CY2012Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2186143	USD
CY2011Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8506933	USD
CY2013Q2	us-gaap	Inventory Net InventoryNet	161636	USD
CY2012Q2	us-gaap	Inventory Net InventoryNet	273490	USD
CY2011Q2	us-gaap	Inventory Net InventoryNet	738207	USD
CY2013Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	221876	USD
CY2012Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	699638	USD
CY2011Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1007630	USD
CY2013Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	16318531	USD
CY2012Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	23230	USD
CY2011Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	3126340	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	45546338	USD
CY2012Q2	us-gaap	Assets Current AssetsCurrent	47687032	USD
CY2011Q2	us-gaap	Assets Current AssetsCurrent	37123930	USD
CY2013Q2	chhe	Property And Equipment Net Excluding Construction In Progress PropertyAndEquipmentNetExcludingConstructionInProgress	1108027	USD
CY2012Q2	chhe	Property And Equipment Net Excluding Construction In Progress PropertyAndEquipmentNetExcludingConstructionInProgress	1155544	USD
CY2011Q2	chhe	Property And Equipment Net Excluding Construction In Progress PropertyAndEquipmentNetExcludingConstructionInProgress	1147281	USD
CY2013Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5627608	USD
CY2012Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	852834	USD
CY2011Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	860163	USD
CY2013Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2156402	USD
CY2012Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	476787	USD
CY2011Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1856	USD
CY2013Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	0	USD
CY2012Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	3305525	USD
CY2011Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	3249014	USD
CY2013Q2	us-gaap	Assets Assets	54438375	USD
CY2012Q2	us-gaap	Assets Assets	53477722	USD
CY2011Q2	us-gaap	Assets Assets	42382244	USD
CY2013Q2	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	123484	USD
CY2012Q2	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	297430	USD
CY2011Q2	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	906208	USD
CY2013Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	431802	USD
CY2012Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	435196	USD
CY2011Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	432924	USD
CY2013Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	191702	USD
CY2012Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	119858	USD
CY2011Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1352906	USD
CY2013Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	245481	USD
CY2012Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	463460	USD
CY2011Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	2657582	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	992469	USD
CY2012Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1315944	USD
CY2013Q2	chhe	Statutory Reserve StatutoryReserve	38679	USD
CY2011	us-gaap	Cost Of Goods Sold CostOfGoodsSold	33335334	USD
CY2013	us-gaap	Gross Profit GrossProfit	974341	USD
CY2012	us-gaap	Gross Profit GrossProfit	24004996	USD
CY2011	us-gaap	Gross Profit GrossProfit	29444644	USD
CY2011Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5349620	USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	6224	USD
CY2012Q2	us-gaap	Common Stock Value CommonStockValue	6224	USD
CY2011Q2	us-gaap	Common Stock Value CommonStockValue	6224	USD
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1462227	USD
CY2012Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1462227	USD
CY2011Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1462227	USD
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4501780	USD
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2664729	USD
CY2011Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2010981	USD
CY2012Q2	chhe	Statutory Reserve StatutoryReserve	38679	USD
CY2011Q2	chhe	Statutory Reserve StatutoryReserve	38679	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	47436996	USD
CY2012Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	47989919	USD
CY2011Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	33514513	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	53445906	USD
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	52161778	USD
CY2011Q2	us-gaap	Stockholders Equity StockholdersEquity	37032624	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54438375	USD
CY2012Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53477722	USD
CY2011Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42382244	USD
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	7727040	USD
CY2012	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	58935570	USD
CY2011	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	62779978	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	6752699	USD
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	34930574	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1123213	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4650695	USD
CY2011	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6000090	USD
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	182687	USD
CY2012	us-gaap	Depreciation And Amortization DepreciationAndAmortization	63463	USD
CY2011	us-gaap	Depreciation And Amortization DepreciationAndAmortization	46578	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	444945	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	311182	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	1750845	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	5025340	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	6046668	USD
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-776504	USD
CY2012	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	18979656	USD
CY2011	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	23397976	USD
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	247513	USD
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	304619	USD
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	227837	USD
CY2013	us-gaap	Interest Expense InterestExpense	0	USD
CY2012	us-gaap	Interest Expense InterestExpense	0	USD
CY2011	us-gaap	Interest Expense InterestExpense	27317	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	247513	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	304619	USD
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.2840
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62239737	shares
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62239737	shares
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62239737	shares
CY2009Q2	us-gaap	Stockholders Equity StockholdersEquity	4302396	USD
CY2010	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4750	USD
CY2010	chhe	Adjustmentstoadditionalpaidincapitalimputedinterestonshareholderloan Adjustmentstoadditionalpaidincapitalimputedinterestonshareholderloan	20315	USD
CY2011	chhe	Adjustmentstoadditionalpaidincapitalimputedinterestonshareholderloan Adjustmentstoadditionalpaidincapitalimputedinterestonshareholderloan	27317	USD
CY2010	us-gaap	Net Income Loss NetIncomeLoss	13254171	USD
CY2010	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	328317	USD
CY2010Q2	us-gaap	Stockholders Equity StockholdersEquity	17909949	USD
CY2011	chhe	Transferredtostatutoryreserve Transferredtostatutoryreserve	0	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	230390	USD
CY2011	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	200520	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-528991	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	19284275	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	23598496	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23932	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4808869	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5924501	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-552923	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	14475406	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	17673995	USD
CY2013	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1837051	USD
CY2012	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	653748	USD
CY2011	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1421363	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1284128	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	15129154	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19095358	USD
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.0089
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.2326
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	110260	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	83580	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-119406	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-477462	USD
CY2011	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	530537	USD
CY2013	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	13798863	USD
CY2012	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-9641494	USD
CY2011	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	8293101	USD
CY2013	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3857625	USD
CY2012	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-325453	USD
CY2011	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	171415	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-345011	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4137785	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	776956	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10489376	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20892290	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9344473	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2943	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	76282	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3134	USD
CY2013	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	1634745	USD
CY2012	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	474803	USD
CY2011	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	0	USD
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1271869	USD
CY2012	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	416950	USD
CY2011	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	948446	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-15664922	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	20759711	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	10400289	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4326	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1556	USD
CY2012	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2011	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2013	chhe	Self Insured Reserve SelfInsuredReserve	0	USD
CY2012	chhe	Self Insured Reserve SelfInsuredReserve	0	USD
CY2011	chhe	Self Insured Reserve SelfInsuredReserve	-222322	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6443089	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-551085	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3134	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	110504	USD
CY2013	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2012	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1556	USD
CY2011	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	110504	USD
CY2010Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13344531	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	23932	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	4808869	USD
CY2011	us-gaap	Income Taxes Paid IncomeTaxesPaid	6911670	USD
CY2013	us-gaap	Interest Paid InterestPaid	0	USD
CY2012	us-gaap	Interest Paid InterestPaid	0	USD
CY2011	us-gaap	Interest Paid InterestPaid	0	USD
CY2013	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4805401	USD
CY2012	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2011	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2013	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	4326	USD
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px" align="justify"><strong>Concentrations of Credit Risk</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2"> </font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px" align="justify">All of the Company’s manufacturing is located in the PRC. There can be no assurance that the Company will be able to successfully continue to manufacture its products and failure to do so would have a material adverse effect on the Company’s financial position, results of operations and cash flows. Also, the success of the Company’s operations is subject to numerous contingencies, some of which are beyond management’s control. These contingencies include general economic conditions, prices of raw materials, competition, governmental and political conditions, and changes in regulations. Since the Company is dependent on trade in the PRC, the Company is subject to various additional political, economic and other uncertainties. Among other risks, the Company’s operations will be subject to the risks of restrictions on transfer of funds, domestic and international customs, changing taxation policies, foreign exchange restrictions, and political and governmental regulations.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2"> </font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px" align="justify">The Company operates in China, which may give rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between U.S. dollars and the Chinese currency RMB. The results of operations denominated in foreign currency are translated at the average rate of exchange during the reporting period.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px" align="justify"><strong>Use of Estimates</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2"> </font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px" align="justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. China Health bases its estimates and judgments on historical experience and on various other assumptions and information that are believed to be reasonable under the circumstances. Estimates and assumptions of future events and their effects cannot be perceived with certainty and, accordingly, these estimates may change as new events occur, as more experience is acquired, as additional information is obtained and as our operating environment changes. The more significant estimates and assumptions by management include, among others, useful lives and residual value of long-lived assets, valuation of inventory, accounts receivable and notes receivable, impairment analysis of long-lived assets, intangible assets and deferred taxes. While the Company believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from those estimates.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2011	chhe	Income Tax Reconciliation At Federal Statutory Income Tax Rate Foreign Enterprise IncomeTaxReconciliationAtFederalStatutoryIncomeTaxRateForeignEnterprise	5899624	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	0	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	151	USD
CY2013Q2	chhe	Statutory Reserve Percentage StatutoryReservePercentage	0.5	pure
CY2013Q2	chhe	Appropriation To Statutory Surplus Reserve AppropriationToStatutorySurplusReserve	38679	USD
CY2013Q2	chhe	Appropriation To Statutory Surplus Reserve AppropriationToStatutorySurplusReserve	250000	CNY
CY2013	chhe	Value Added Tax Goods Percentage ValueAddedTaxGoodsPercentage	13% or 17%
CY2011	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	6898	USD
CY2013Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	28839609	USD
CY2012Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	44500205	USD
CY2011Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	23740502	USD
CY2013Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	0	USD
CY2012Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	4326	USD
CY2011Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	4318	USD
CY2013	chhe	Total Payment To Contractor TotalPaymentToContractor	1466419	USD
CY2013	chhe	Total Payment To Contractor TotalPaymentToContractor	9000000	CNY
CY2012	chhe	Total Payment To Contractor TotalPaymentToContractor	1416654	USD
CY2012	chhe	Total Payment To Contractor TotalPaymentToContractor	9000000	CNY
CY2011	chhe	Total Payment To Contractor TotalPaymentToContractor	1392434	USD
CY2011	chhe	Total Payment To Contractor TotalPaymentToContractor	9000000	CNY
CY2013Q2	chhe	Deferred Expenses DeferredExpenses	156750	USD
CY2012Q2	chhe	Deferred Expenses DeferredExpenses	600321	USD
CY2011Q2	chhe	Deferred Expenses DeferredExpenses	900928	USD
CY2013Q2	us-gaap	Supplies Supplies	65126	USD
CY2012Q2	us-gaap	Supplies Supplies	99317	USD
CY2011Q2	us-gaap	Supplies Supplies	106702	USD
CY2013Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	USD
CY2012Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	USD
CY2011Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	USD
CY2007Q2	chhe	Pharmaceutical Patents PharmaceuticalPatents	518135	USD
CY2007Q2	chhe	Pharmaceutical Patents PharmaceuticalPatents	3180000	CNY
CY2013Q1	chhe	Supplemental Product Patents SupplementalProductPatents	4888063	USD
CY2013Q1	chhe	Supplemental Product Patents SupplementalProductPatents	30000000	CNY
CY2013Q2	chhe	Supplemental Product Patents SupplementalProductPatents	4765862	USD
CY2004Q2	chhe	Land Use Rights Purchase LandUseRightsPurchase	855085	USD
CY2004Q2	chhe	Land Use Rights Purchase LandUseRightsPurchase	5248000	CNY
CY2009	chhe	Payments To Acquire Land Use Rights PaymentsToAcquireLandUseRights	177597	USD
CY2009	chhe	Payments To Acquire Land Use Rights PaymentsToAcquireLandUseRights	1089984	CNY
CY2013Q2	chhe	Land Use Rights And Improvements LandUseRightsAndImprovements	861746	USD
CY2012Q2	chhe	Land Use Rights And Improvements LandUseRightsAndImprovements	852834	USD
CY2011Q2	chhe	Land Use Rights And Improvements LandUseRightsAndImprovements	860163	USD
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.25	pure
CY2013	chhe	Value Added Tax Services Percentage ValueAddedTaxServicesPercentage	0.17	pure
CY2013	chhe	Sales Tax Description SalesTaxDescription	Pursuant to the tax law and regulations of PRC, China Health is obligated to pay 7% and 5% of the annual VAT paid as tax on maintaining and building cities and education additional fee, both of which belong to sales-related taxes.
CY2013	chhe	Sales Taxes And Sales Related Taxes SalesTaxesAndSalesRelatedTaxes	141714	USD
CY2012	chhe	Sales Taxes And Sales Related Taxes SalesTaxesAndSalesRelatedTaxes	992789	USD
CY2011	chhe	Sales Taxes And Sales Related Taxes SalesTaxesAndSalesRelatedTaxes	1062267	USD
CY2013Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	36468	USD
CY2012Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	25127	USD
CY2011Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	24272	USD
CY2013Q2	chhe	Appropriation To Statutory Surplus Reserve Percentage AppropriationToStatutorySurplusReservePercentage	0.1	pure
CY2013	chhe	Income Tax Reconciliation Nondeductible Expense Temporary Differences IncomeTaxReconciliationNondeductibleExpenseTemporaryDifferences	23932	USD
CY2012	chhe	Income Tax Reconciliation Nondeductible Expense Temporary Differences IncomeTaxReconciliationNondeductibleExpenseTemporaryDifferences	3610	USD
CY2011	chhe	Income Tax Reconciliation Nondeductible Expense Temporary Differences IncomeTaxReconciliationNondeductibleExpenseTemporaryDifferences	215314	USD
CY2013	chhe	Income Tax Reconciliation Nondeductible Expense Permanent Differences IncomeTaxReconciliationNondeductibleExpensePermanentDifferences	0	USD
CY2012	chhe	Income Tax Reconciliation Nondeductible Expense Permanent Differences IncomeTaxReconciliationNondeductibleExpensePermanentDifferences	-15961	USD
CY2011	chhe	Income Tax Reconciliation Nondeductible Expense Permanent Differences IncomeTaxReconciliationNondeductibleExpensePermanentDifferences	-206914	USD
CY2013Q2	chhe	Provisions For Sale Returns ProvisionsForSaleReturns	39299	USD
CY2012Q2	chhe	Provisions For Sale Returns ProvisionsForSaleReturns	294737	USD
CY2011Q2	chhe	Provisions For Sale Returns ProvisionsForSaleReturns	904227	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	USD
CY2009Q3	chhe	Payments For Retainer Fees PaymentsForRetainerFees	814677	USD
CY2009Q3	chhe	Payments For Retainer Fees PaymentsForRetainerFees	5000000	CNY
CY2013Q2	us-gaap	Due From Employees Current DueFromEmployeesCurrent	12334	USD
CY2012Q2	us-gaap	Due From Employees Current DueFromEmployeesCurrent	11915	USD
CY2011Q2	us-gaap	Due From Employees Current DueFromEmployeesCurrent	2955	USD
CY2013Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	0	USD
CY2012Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	0	USD
CY2011Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	25992	USD
CY2013Q2	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	12653	USD
CY2012Q2	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	11315	USD
CY2011Q2	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	3094	USD
CY2013Q2	chhe	Inventory Supplies And Packing Materials InventorySuppliesAndPackingMaterials	17417	USD
CY2012Q2	chhe	Inventory Supplies And Packing Materials InventorySuppliesAndPackingMaterials	18131	USD
CY2011Q2	chhe	Inventory Supplies And Packing Materials InventorySuppliesAndPackingMaterials	63804	USD
CY2013Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	41209	USD
CY2012Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	61624	USD
CY2011Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	154770	USD
CY2013Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	43050	USD
CY2012Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	56572	USD
CY2011Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	191506	USD
CY2013Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	59960	USD
CY2012Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	137163	USD
CY2011Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	328127	USD
CY2013	us-gaap	Depreciation Depreciation	89563	USD
CY2012	us-gaap	Depreciation Depreciation	87974	USD
CY2013	chhe	Depreciation Expense Charged To Operations DepreciationExpenseChargedToOperations	41860	USD
CY2012	chhe	Depreciation Expense Charged To Operations DepreciationExpenseChargedToOperations	41177	USD
CY2011	chhe	Depreciation Expense Charged To Operations DepreciationExpenseChargedToOperations	39493	USD
CY2013	us-gaap	Cost Of Goods Sold Depreciation CostOfGoodsSoldDepreciation	47703	USD
CY2012	us-gaap	Cost Of Goods Sold Depreciation CostOfGoodsSoldDepreciation	46797	USD
CY2011	us-gaap	Cost Of Goods Sold Depreciation CostOfGoodsSoldDepreciation	24955	USD
CY2011	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	9579	USD
CY2011Q2	chhe	Income Taxes Payable Current IncomeTaxesPayableCurrent	1539224	USD
CY2013Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	463156	USD
CY2012Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	359426	USD
CY2011Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	266795	USD
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1108027	USD
CY2012Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1155544	USD
CY2011Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1147281	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	140827	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22286	USD
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	19132	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	293138	USD
CY2012Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	144802	USD
CY2011Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	120418	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5627608	USD
CY2012Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	852834	USD
CY2011Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	860163	USD
CY2012	chhe	Income Tax Reconciliation At Federal Statutory Income Tax Rate Foreign Enterprise IncomeTaxReconciliationAtFederalStatutoryIncomeTaxRateForeignEnterprise	4821069	USD
CY2012Q2	chhe	Income Taxes Payable Current IncomeTaxesPayableCurrent	214414	USD
CY2013Q2	chhe	Income Taxes Payable Current IncomeTaxesPayableCurrent	0	USD
CY2013Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	213317	USD
CY2012Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	208269	USD
CY2011Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	998420	USD
CY2013Q2	chhe	City And Supplement Taxes Current CityAndSupplementTaxesCurrent	25605	USD
CY2012Q2	chhe	City And Supplement Taxes Current CityAndSupplementTaxesCurrent	24996	USD
CY2011Q2	chhe	City And Supplement Taxes Current CityAndSupplementTaxesCurrent	69892	USD
CY2013Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	6559	USD
CY2012Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	15781	USD
CY2011Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	50046	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	23932	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4808869	USD
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5924501	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-528991	USD
CY2012	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	19284275	USD
CY2011	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	23598496	USD
CY2013	chhe	Income Tax Reconciliation At Federal Statutory Income Tax Rate Foreign Enterprise IncomeTaxReconciliationAtFederalStatutoryIncomeTaxRateForeignEnterprise	0	USD
CY2011	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	25763	USD
CY2013Q2	chhe	Appropriation To Statutory Public Welfare Fund Percentage AppropriationToStatutoryPublicWelfareFundPercentage	0.1	pure
CY2013Q2	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	38679	USD
CY2012Q2	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	38679	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	513543	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	738415	USD
CY2012Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	51414	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	47093	USD
CY2011Q2	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	38679	USD
CY2013Q2	chhe	Reserve Commitment Outstanding ReserveCommitmentOutstanding	0	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-552923	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14475406	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	17673995	USD
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62239737	shares
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62239737	shares
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62239737	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62239737	shares
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62239737	shares
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62239737	shares
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.0089
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.2326
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.2840
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.0089
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.2326
CY2011	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.2840
CY2013	us-gaap	Dilutive Securities DilutiveSecurities		USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	15337	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	25809	USD
CY2013Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	649626	USD
CY2013Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	0	USD
CY2013Q1	us-gaap	Assets Assets	54166650	USD
CY2013Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	304192	USD
CY2013Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	431405	USD
CY2013Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	240430	USD
CY2013Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	283541	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3442839	USD
CY2012Q2	chhe	Reserve Commitment Outstanding ReserveCommitmentOutstanding	0	USD
CY2011Q2	chhe	Reserve Commitment Outstanding ReserveCommitmentOutstanding	0	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	81975	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	120491	USD
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	120152	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	358658	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	360200	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45942099	USD
CY2013Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4631	USD
CY2013Q1	us-gaap	Inventory Net InventoryNet	196620	USD
CY2013Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	24443	USD
CY2013Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	545098	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	46712891	USD
CY2013Q1	chhe	Property And Equipment Net Excluding Construction In Progress PropertyAndEquipmentNetExcludingConstructionInProgress	1117077	USD
CY2013Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5687056	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1259568	USD
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	6224	USD
CY2013Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1462227	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3863744	USD
CY2013Q1	chhe	Statutory Reserve StatutoryReserve	38679	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	47536208	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	52907082	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54166650	USD
CY2013Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2479660	USD
CY2012Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	11250503	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5938862	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	56164111	USD
CY2013Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2305756	USD
CY2012Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	6406449	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5059918	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	33777650	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	173904	USD
CY2012Q1	us-gaap	Gross Profit GrossProfit	4844054	USD
	us-gaap	Gross Profit GrossProfit	878944	USD
	us-gaap	Gross Profit GrossProfit	22386461	USD
CY2013Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	377999	USD
CY2012Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	566849	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1093578	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4181592	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-429895	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	18713621	USD
	us-gaap	Interest Expense InterestExpense	0	USD
	us-gaap	Interest Expense InterestExpense	20602	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	66951	USD
CY2012Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	75953	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	190490	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	212174	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-272688	USD
CY2013Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15053	USD
	us-gaap	Operating Expenses OperatingExpenses	1499329	USD
	us-gaap	Operating Expenses OperatingExpenses	3885014	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-339639	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4105639	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-620385	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	18501447	USD
CY2013Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	66951	USD
CY2012Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	82860	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	190490	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	232776	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	0	USD
CY2012Q1	us-gaap	Interest Expense InterestExpense	6907	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	93	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	550167	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23816	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4588768	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-272781	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	3631425	USD
	us-gaap	Net Income Loss NetIncomeLoss	-453711	USD
	us-gaap	Net Income Loss NetIncomeLoss	14124853	USD
CY2013Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	164110	USD
CY2012Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-6373	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1199015	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1158748	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-108671	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3625052	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	745304	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	15283601	USD
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.0044
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.0583
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.0073
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.2269
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62239737	shares
CY2012Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62239737	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62239737	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62239737	shares
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2929	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	76071	USD
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	160308	USD
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	479327	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4945340	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-555398	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4326	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	82649	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	81975	USD
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-2208627	USD
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-2694974	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-82302	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-42258	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3453206	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-356857	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8852	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3564666	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5364221	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13756853	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1023013	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	791612	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1437568	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	13993067	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37737887	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	23816	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	5618304	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4782103	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	4326	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>Use of Estimates</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2"> </font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The preparation of financial statements in conformity with US GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and judgments on historical experience and on various other assumptions and information that are believed to be reasonable under the circumstances. Estimates and assumptions of future events and their effects cannot be perceived with certainty and, accordingly, these estimates may change as new events occur, as more experience is acquired, as additional information is obtained and as our operating environment changes. The more significant estimates and assumptions by management include, among others; useful lives and residual value of long-lived assets, valuation of inventory, accounts receivable and notes receivable, impairment analysis of long-lived assets, intangible assets and deferred taxes. While the Company believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from those estimates.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q1	chhe	Inventory Supplies And Packing Materials InventorySuppliesAndPackingMaterials	20079	USD
CY2011Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	14401135	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2754162	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	27371201	USD
CY2012Q4	us-gaap	Gross Profit GrossProfit	368380	USD
CY2011Q4	us-gaap	Gross Profit GrossProfit	9572477	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>Concentrations of Credit Risk</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2"> </font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> All of the Company’s manufacturing is located in the PRC. There can be no assurance that the Company will be able to successfully continue to manufacture its products and failure to do so would have a material adverse effect on the Company’s financial position, results of operations and cash flows. Also, the success of the Company’s operations is subject to numerous contingencies, some of which are beyond management’s control. These contingencies include general economic conditions, prices of raw materials, competition, governmental and political conditions, and changes in regulations. Since the Company is dependent on trade in the PRC, the Company is subject to various additional political, economic and other uncertainties. Among other risks, the Company’s operations will be subject to the risks of restrictions on transfer of funds, domestic and international customs, changing taxation policies, foreign exchange restrictions, and political and governmental regulations.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2"> </font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The Company operates in China, which may give rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between U.S. dollars and the Chinese currency RMB. The results of operations denominated in foreign currency are translated at the average rate of exchange during the reporting period.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-280746	USD
	us-gaap	Gross Profit GrossProfit	705040	USD
	us-gaap	Gross Profit GrossProfit	18795937	USD
CY2012Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	361514	USD
CY2011Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2286370	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	715579	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4129519	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49866019	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1074414	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	217054	USD
CY2012Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	24048	USD
CY2012Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	461437	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	51642972	USD
CY2012Q4	chhe	Property And Equipment Net Excluding Construction In Progress PropertyAndEquipmentNetExcludingConstructionInProgress	1135432	USD
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	859291	USD
CY2013Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	45942099	USD
CY2013Q1	chhe	Provisions For Sale Returns ProvisionsForSaleReturns	301485	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	14395809	USD
CY2012Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	62059	USD
CY2011Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	76778	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	123539	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	149916	USD
CY2012Q4	us-gaap	Interest Expense InterestExpense	0	USD
CY2011Q4	us-gaap	Interest Expense InterestExpense	6595	USD
	us-gaap	Interest Expense InterestExpense	0	USD
	us-gaap	Interest Expense InterestExpense	13695	USD
CY2013Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	59270	USD
CY2013Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	50620	USD
CY2013Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	66651	USD
CY2012Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	647614	USD
CY2012Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	0	USD
CY2013Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	239226	USD
CY2012Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	600321	USD
CY2013Q1	us-gaap	Supplies Supplies	305872	USD
	chhe	Depreciation Expense Charged To Operations DepreciationExpenseChargedToOperations	31649	USD
	chhe	Depreciation Expense Charged To Operations DepreciationExpenseChargedToOperations	31937	USD
	us-gaap	Cost Of Goods Sold Depreciation CostOfGoodsSoldDepreciation	35556	USD
	us-gaap	Cost Of Goods Sold Depreciation CostOfGoodsSoldDepreciation	35095	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3699634	USD
CY2012Q4	chhe	Statutory Reserve StatutoryReserve	38679	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	47808989	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	53015753	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54285309	USD
CY2013Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	435537	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1117077	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15444	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14493	USD
CY2012Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	62059	USD
CY2011Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	70183	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	123539	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	136221	USD
CY2012Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-67201	USD
CY2011Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7220404	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-157207	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14532030	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	163718	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5687056	USD
CY2012Q4	us-gaap	Assets Assets	54285309	USD
CY2012Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	303259	USD
CY2012Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	431459	USD
CY2012Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	222166	USD
CY2012Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	312672	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1269556	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	6224	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1462227	USD
CY2012Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16040	USD
CY2011Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15862	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	11800	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	17342	USD
CY2012Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2005894	USD
CY2011Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	23973612	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3459202	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	46167138	USD
CY2012Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1637514	USD
CY2012Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15980	USD
CY2011Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2012Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2011Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2012Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	32040	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	30561	USD
CY2012Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	120086	USD
CY2011Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	120024	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	238167	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	240048	USD
CY2012Q4	us-gaap	Operating Expenses OperatingExpenses	497640	USD
CY2011Q4	us-gaap	Operating Expenses OperatingExpenses	2422256	USD
	us-gaap	Operating Expenses OperatingExpenses	985786	USD
	us-gaap	Operating Expenses OperatingExpenses	4400128	USD
CY2012Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-129260	USD
CY2011Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7150221	USD
CY2011Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2041873	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23723	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4038601	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-83181	USD
CY2011Q4	us-gaap	Net Income Loss NetIncomeLoss	5178531	USD
	us-gaap	Net Income Loss NetIncomeLoss	-180930	USD
	us-gaap	Net Income Loss NetIncomeLoss	10493429	USD
CY2012Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	465558	USD
CY2011Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	631937	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1034905	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1165121	USD
CY2012Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	382377	USD
CY2011Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5810468	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	853975	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11658550	USD
CY2012Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.0013
CY2011Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.0832
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.0029
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.1686
CY2012Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62239737	shares
CY2011Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62239737	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62239737	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62239737	shares
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	55565	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	53841	USD
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-1142032	USD
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	8799797	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-61164	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	199859	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3520750	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-252405	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3535	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1808701	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4602116	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3622415	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2866	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	76076	USD
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	159679	USD
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	479357	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-162545	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-555433	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	479357	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4326	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	926243	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	796996	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5361488	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3863978	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27608798	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	23723	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	6911670	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	4326	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	479357	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>Use of Estimates</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2"> </font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The preparation of financial statements in conformity with US GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and judgments on historical experience and on various other assumptions and information that are believed to be reasonable under the circumstances. Estimates and assumptions of future events and their effects cannot be perceived with certainty and, accordingly, these estimates may change as new events occur, as more experience is acquired, as additional information is obtained and as our operating environment changes. The more significant estimates and assumptions by management include, among others; useful lives and residual value of long-lived assets, valuation of inventory, accounts receivable and notes receivable, impairment analysis of long-lived assets, intangible assets and deferred taxes. While the Company believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from those estimates.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2011Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1963173	USD
CY2012Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16000	USD
CY2011Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14699	USD
CY2012Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	118081	USD
CY2011Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	USD
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	488146	USD
CY2012Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4326	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>Concentrations of Credit Risk</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2"> </font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> All of the Company’s manufacturing is located in the PRC. There can be no assurance that the Company will be able to successfully continue to manufacture its products and failure to do so would have a material adverse effect on the Company’s financial position, results of operations and cash flows. Also, the success of the Company’s operations is subject to numerous contingencies, some of which are beyond management’s control. These contingencies include general economic conditions, prices of raw materials, competition, governmental and political conditions, and changes in regulations. Since the Company is dependent on trade in the PRC, the Company is subject to various additional political, economic and other uncertainties. Among other risks, the Company’s operations will be subject to the risks of restrictions on transfer of funds, domestic and international customs, changing taxation policies, foreign exchange restrictions, and political and governmental regulations.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2"> </font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The Company operates in China, which may give rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between U.S. dollars and the Chinese currency RMB. The results of operations denominated in foreign currency are translated at the average rate of exchange during the reporting period.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10256	USD
CY2011Q3	us-gaap	Operating Expenses OperatingExpenses	1977872	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-151486	USD
CY2011Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7245588	USD
CY2012Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	61480	USD
CY2011Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	73138	USD
CY2011Q3	us-gaap	Interest Expense InterestExpense	7100	USD
CY2012Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	61480	USD
CY2012Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	70283	USD
CY2012Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	44561	USD
CY2012Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	80946	USD
CY2012Q4	chhe	Inventory Supplies And Packing Materials InventorySuppliesAndPackingMaterials	21264	USD
CY2010Q3	chhe	Contractor Certificate Registration Period ContractorCertificateRegistrationPeriod	P3Y
CY2011Q3	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	378429	USD
CY2012Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	49866019	USD
CY2012Q4	chhe	Provisions For Sale Returns ProvisionsForSaleReturns	300550	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9922	USD
CY2011Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	66038	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-90006	USD
CY2011Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7311626	USD
CY2012Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7743	USD
CY2012Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	360161	USD
CY2012Q4	us-gaap	Supplies Supplies	101276	USD
CY2012Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	23808	USD
CY2012Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	586379	USD
CY2012Q3	us-gaap	Assets Current AssetsCurrent	47932749	USD
CY2012Q3	chhe	Property And Equipment Net Excluding Construction In Progress PropertyAndEquipmentNetExcludingConstructionInProgress	1145350	USD
CY2012Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	856950	USD
	chhe	Depreciation Expense Charged To Operations DepreciationExpenseChargedToOperations	21784	USD
	chhe	Depreciation Expense Charged To Operations DepreciationExpenseChargedToOperations	20639	USD
	us-gaap	Cost Of Goods Sold Depreciation CostOfGoodsSoldDepreciation	23525	USD
	us-gaap	Cost Of Goods Sold Depreciation CostOfGoodsSoldDepreciation	23280	USD
CY2011Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1996728	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-97749	USD
CY2011Q3	us-gaap	Net Income Loss NetIncomeLoss	5314898	USD
CY2012Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	569347	USD
CY2011Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	533184	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	412321	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1135432	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	158026	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	859291	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	471598	USD
CY2011Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5848082	USD
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.0016
CY2011Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.0854
CY2012Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62239737	shares
CY2011Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62239737	shares
CY2012Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	27578	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	11114	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	11134	USD
CY2012Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2012Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2012Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	62239737	shares
CY2012Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62239737	shares
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45846175	USD
CY2012Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1207483	USD
CY2012Q3	us-gaap	Inventory Net InventoryNet	268904	USD
CY2012Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	481960	USD
CY2012Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	3341395	USD
CY2012Q3	us-gaap	Assets Assets	53758404	USD
CY2012Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	300636	USD
CY2012Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	431190	USD
CY2012Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	138790	USD
CY2012Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	254412	USD
CY2012Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1125028	USD
CY2012Q3	us-gaap	Common Stock Value CommonStockValue	6224	USD
CY2012Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1462227	USD
CY2012Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3234076	USD
CY2012Q3	chhe	Statutory Reserve StatutoryReserve	38679	USD
CY2012Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	47892170	USD
CY2012Q3	us-gaap	Stockholders Equity StockholdersEquity	52633376	USD
CY2012Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53758404	USD
CY2012Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1453308	USD
CY2011Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	22193526	USD
CY2012Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1116648	USD
CY2011Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	12970066	USD
CY2012Q3	us-gaap	Gross Profit GrossProfit	336660	USD
CY2011Q3	us-gaap	Gross Profit GrossProfit	9223460	USD
CY2012Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	354065	USD
CY2011Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26288	USD
CY2012Q3	us-gaap	Interest Expense InterestExpense	0	USD
CY2012Q3	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-991520	USD
CY2011Q3	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	4975798	USD
CY2012Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7474	USD
CY2011Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	158714	USD
CY2012Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-119581	USD
CY2011Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-124199	USD
CY2012Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-194377	USD
CY2011Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1994894	USD
CY2012Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	854027	USD
CY2011Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2332867	USD
CY2012Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2011Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	66031	USD
CY2012Q3	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	0	USD
CY2011Q3	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	378429	USD
CY2012Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2011Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-444460	USD
CY2012Q3	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2011Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	378429	USD
CY2012Q3	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	491943	USD
CY2011Q3	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	331936	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1341644	USD
CY2011Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2598772	USD
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26343592	USD
CY2012Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	7743	USD
CY2011Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	4076657	USD
CY2012Q3	us-gaap	Interest Paid InterestPaid	0	USD
CY2011Q3	us-gaap	Interest Paid InterestPaid	0	USD
CY2012Q3	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	4326	USD
CY2011Q3	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2012Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	45846175	USD
CY2012Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	0	USD
CY2012Q3	us-gaap	Use Of Estimates UseOfEstimates	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>Use of Estimates</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2"> </font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The preparation of financial statements in conformity with US GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. China Health bases its estimates and judgments on historical experience and on various other assumptions and information that are believed to be reasonable under the circumstances. Estimates and assumptions of future events and their effects cannot be perceived with certainty and, accordingly, these estimates may change as new events occur, as more experience is acquired, as additional information is obtained and as our operating environment changes. The more significant estimates and assumptions by management include, among others; useful lives and residual value of long-lived assets, valuation of inventory, accounts receivable and notes receivable, impairment analysis of long-lived assets, intangible assets and deferred taxes. While the Company believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from those estimates.</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2012Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	55189	USD
CY2012Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	38237	USD
CY2012Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	153397	USD
CY2012Q3	chhe	Inventory Supplies And Packing Materials InventorySuppliesAndPackingMaterials	22081	USD
CY2012Q3	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>Concentrations of Credit Risk</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2"> </font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <font style=" FONT-SIZE: 10pt">All of the Company’s manufacturing is located in the PRC. There can be no assurance that the Company will be able to successfully continue to manufacture its products and failure to do so would have a material adverse effect on the Company’s financial position,</font> <font style=" FONT-SIZE: 10pt">results of operations and cash flows. Also, the success of the Company’s operations is subject to numerous contingencies, some of which are beyond management’s control. These contingencies include general economic conditions, prices of raw materials, competition, governmental and political conditions, and changes in regulations. Since the Company is dependent on trade in the PRC, the Company is subject to various additional political, economic and other uncertainties. Among other risks, the Company’s operations will be subject to the risks of restrictions on transfer of funds, domestic and international customs, changing taxation policies, foreign exchange restrictions, and political and governmental regulations.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2"> </font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <font style=" FONT-SIZE: 10pt">The Company operates in China, which may give rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between U.S. dollars and the Chinese currency RMB.  The results of operations denominated in foreign currency are translated at the average rate of exchange during the reporting period.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2012Q3	chhe	Provisions For Sale Returns ProvisionsForSaleReturns	297935	USD
CY2012Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	485984	USD
CY2012Q3	us-gaap	Supplies Supplies	100395	USD
CY2012Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5085	USD
CY2011Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4940	USD
CY2012Q3	us-gaap	Depreciation Depreciation	22493	USD
CY2011Q3	us-gaap	Depreciation Depreciation	21348	USD
CY2012Q3	chhe	Depreciation Expense Charged To Operations DepreciationExpenseChargedToOperations	10915	USD
CY2011Q3	chhe	Depreciation Expense Charged To Operations DepreciationExpenseChargedToOperations	9759	USD
CY2012Q3	us-gaap	Cost Of Goods Sold Depreciation CostOfGoodsSoldDepreciation	11578	USD
CY2011Q3	us-gaap	Cost Of Goods Sold Depreciation CostOfGoodsSoldDepreciation	11589	USD
CY2012Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	386059	USD
CY2012Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1145350	USD
CY2012Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	151512	USD
CY2012Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	856950	USD
CY2012Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5510	USD
CY2011Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	3763	USD

Files In Submission

Name	View Source	Status
0001144204-13-055291-index-headers.html	Edgar Link	pending
0001144204-13-055291-index.html	Edgar Link	pending
0001144204-13-055291.txt	Edgar Link	pending
0001144204-13-055291-xbrl.zip	Edgar Link	pending
chhe-20130630.xml	Edgar Link	completed
chhe-20130630.xsd	Edgar Link	pending
chhe-20130630_cal.xml	Edgar Link	unprocessable
chhe-20130630_def.xml	Edgar Link	unprocessable
chhe-20130630_lab.xml	Edgar Link	unprocessable
chhe-20130630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tchart31a.jpg	Edgar Link	pending
v356401_10k.htm	Edgar Link	pending
v356401_ex10-22.htm	Edgar Link	pending
v356401_ex10-23.htm	Edgar Link	pending
v356401_ex10-24.htm	Edgar Link	pending
v356401_ex23-1.htm	Edgar Link	pending
v356401_ex31-1.htm	Edgar Link	pending
v356401_ex31-2.htm	Edgar Link	pending
v356401_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CHHE
China Health Industries Holdings, Inc. Stock $chhe

2013 Q1 Form 10-K Financial Statement

#000114420413055291 Filed on October 15, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHHE China Health Industries Holdings, Inc. Stock $chhe

2013 Q1 Form 10-K Financial Statement

#000114420413055291 Filed on October 15, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHHE
China Health Industries Holdings, Inc. Stock $chhe